Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|16|2674-2677

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.16, 2015-08, pp. : 2674-2677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human papillomavirus testing improves follow-up after treatment for cervical intraepithelial neoplasia

By Coup Veerle MH   Berkhof Johannes  

Women's Health, Vol. 4, Iss. 2, 2008-03 ,pp. : 103-105

Future Medicine

Access to resources Recommend Favorite

Clearance of human papillomavirus infection after successful conization in patients with cervical intraepithelial neoplasia

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 126, Iss. 8, 2010-04 ,pp. : 1903-1909

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term follow‐up of the risk for cervical intraepithelial neoplasia grade 2 or worse in HPV‐negative women after conization

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2927-2933

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term risk of cervical intraepithelial neoplasia grade 3 or worse according to high‐risk human papillomavirus genotype and semi‐quantitative viral load among 33,288 women with normal cervical cytology

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 1, 2015-07 ,pp. : 193-203

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia

By Paavonen Jorma  

Therapy, Vol. 5, Iss. 3, 2008-05 ,pp. : 325-328

Future Medicine

Access to resources Recommend Favorite